Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administration

NCT01352065 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Hypertension

Interventions

DRUG: Bosentan
DRUG: Ambrisentan
DRUG: Placebo

Sponsor

Center for Health Sciences, Serbia